Status:
UNKNOWN
Passive Evaluation in Operational Environment of the AI Clinician Decision Support System for Sepsis Treatment
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
Conditions:
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
Sepsis, or systemic infection, is a common reason for ICU admission and death throughout the world. Despite advances in the way we treat this condition, it remains a significant economic and healthcar...
Detailed Description
Sepsis is life-threatening organ dysfunction due to severe infection and affects 250,000 patients annually in the UK (pre-COVID-19), of whom 48,000 die. In addition, virtually all COVID-19 intensive c...
Eligibility Criteria
Inclusion
- For patients:
- Adult patient \> 18 years old
- Admitted to an intensive care unit
- Likely or confirmed diagnosis of sepsis as per sepsis-3 definition (as defined in the glossary)
- ICU length of stay \> 24h
- For Evaluators:
- \- ICU doctors at the senior registrar, ICU fellow or consultant level
Exclusion
- For patients:
- Not for full active care, e.g. not for vasopressors
- Not expected to survive more than 24h
- Elective surgical admission (these patients are regularly on antibiotics but given as a prophylaxis, with no sepsis)
- Opted-out for use of their data for research (NHS and NHS-X website)
- For both patients and evaluators:
- Declined participation No patient consent is required
Key Trial Info
Start Date :
March 24 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05287477
Start Date
March 24 2022
End Date
August 31 2024
Last Update
October 27 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Univeristy College London Hospitals NHS Foundation Trust
London, United Kingdom, NW1 2PG
2
Imperial College Hospitals NHS Trust
London, United Kingdom, W2 1BL